BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 20477588)

  • 1. Insight into the inflammasome and caspase-activating mechanisms.
    Gaide O; Hoffman HM
    Expert Rev Clin Immunol; 2008 Jan; 4(1):61-77. PubMed ID: 20477588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute neurodegeneration and the inflammasome: central processor for danger signals and the inflammatory response?
    Trendelenburg G
    J Cereb Blood Flow Metab; 2008 May; 28(5):867-81. PubMed ID: 18212795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms involved in inflammasome activation.
    Bryant C; Fitzgerald KA
    Trends Cell Biol; 2009 Sep; 19(9):455-64. PubMed ID: 19716304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orchestration of pathogen recognition by inflammasome diversity: Variations on a common theme.
    Martinon F
    Eur J Immunol; 2007 Nov; 37(11):3003-6. PubMed ID: 17960661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens.
    Brodsky IE; Monack D
    Semin Immunol; 2009 Aug; 21(4):199-207. PubMed ID: 19539499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation.
    Faustin B; Lartigue L; Bruey JM; Luciano F; Sergienko E; Bailly-Maitre B; Volkmann N; Hanein D; Rouiller I; Reed JC
    Mol Cell; 2007 Mar; 25(5):713-24. PubMed ID: 17349957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammasomes and rheumatic diseases: evolving concepts.
    Sidiropoulos PI; Goulielmos G; Voloudakis GK; Petraki E; Boumpas DT
    Ann Rheum Dis; 2008 Oct; 67(10):1382-9. PubMed ID: 17921182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primer: inflammasomes and interleukin 1beta in inflammatory disorders.
    Church LD; Cook GP; McDermott MF
    Nat Clin Pract Rheumatol; 2008 Jan; 4(1):34-42. PubMed ID: 18172447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From inflammasomes to fevers, crystals and hypertension: how basic research explains inflammatory diseases.
    McDermott MF; Tschopp J
    Trends Mol Med; 2007 Sep; 13(9):381-8. PubMed ID: 17822957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammasomes as microbial sensors.
    Franchi L; Muñoz-Planillo R; Reimer T; Eigenbrod T; Núñez G
    Eur J Immunol; 2010 Mar; 40(3):611-5. PubMed ID: 20201013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sunburned skin activates inflammasomes.
    Faustin B; Reed JC
    Trends Cell Biol; 2008 Jan; 18(1):4-8. PubMed ID: 18083030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of uric acid crystal-mediated autoinflammation.
    Martinon F
    Immunol Rev; 2010 Jan; 233(1):218-32. PubMed ID: 20193002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes.
    Feldmeyer L; Keller M; Niklaus G; Hohl D; Werner S; Beer HD
    Curr Biol; 2007 Jul; 17(13):1140-5. PubMed ID: 17600714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation.
    Mariathasan S; Monack DM
    Nat Rev Immunol; 2007 Jan; 7(1):31-40. PubMed ID: 17186029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammasomes and inflammatory caspases in skin inflammation.
    Iversen L; Johansen C
    Expert Rev Mol Diagn; 2008 Nov; 8(6):697-705. PubMed ID: 18999922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of endogenous triggers on trauma-associated inflammation.
    Zedler S; Faist E
    Curr Opin Crit Care; 2006 Dec; 12(6):595-601. PubMed ID: 17077693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice.
    Abulafia DP; de Rivero Vaccari JP; Lozano JD; Lotocki G; Keane RW; Dietrich WD
    J Cereb Blood Flow Metab; 2009 Mar; 29(3):534-44. PubMed ID: 19066616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation.
    Zhang H; Chen X; Zong B; Yuan H; Wang Z; Wei Y; Wang X; Liu G; Zhang J; Li S; Cheng G; Wang Y; Ma Y
    J Cell Mol Med; 2018 Sep; 22(9):4437-4448. PubMed ID: 29993180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genipin suppresses NLRP3 inflammasome activation through uncoupling protein-2.
    Rajanbabu V; Galam L; Fukumoto J; Enciso J; Tadikonda P; Lane TN; Bandyopadhyay S; Parthasarathy PT; Cho Y; Cho SH; Lee YC; Lockey RF; Kolliputi N
    Cell Immunol; 2015 Sep; 297(1):40-5. PubMed ID: 26123077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial immunopathogenesis of multiple sclerosis: innate immune response.
    Hernández-Pedro NY; Espinosa-Ramirez G; de la Cruz VP; Pineda B; Sotelo J
    Clin Dev Immunol; 2013; 2013():413465. PubMed ID: 24174969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.